We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

43 hedge funds and large institutions have $127M invested in Neos Therapeutics, Inc in 2015 Q3 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+43
Holders Change %
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
43
Increased
Reduced
Closed
Calls
$656K
Puts
Net Calls
+$656K
Net Calls Change
+$656K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
26
Millennium Management
New York
$286K +$300K +13,628 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$246K +$258K +11,713 New
Northern Trust
28
Northern Trust
Illinois
$241K +$253K +11,462 New
Goldman Sachs
29
Goldman Sachs
New York
$227K +$238K +10,820 New
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$212K +$223K +10,100 New
Norges Bank
31
Norges Bank
Norway
$204K +$214K +9,700 New
TA
32
Teachers Advisors
New York
$118K +$124K +5,628 New
UBS Group
33
UBS Group
Switzerland
$91K +$95.2K +4,321 New
Morgan Stanley
34
Morgan Stanley
New York
$71K +$75K +3,403 New
TRCT
35
Tower Research Capital (TRC)
New York
$58K +$61.3K +2,781 New
BA
36
BlackRock Advisors
Delaware
$46K +$47.9K +2,175 New
SO
37
STRS Ohio
Ohio
$37K +$39.7K +1,800 New
NFA
38
Nationwide Fund Advisors
Ohio
$23K +$24.6K +1,116 New
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$21.5K +$22.6K +1,024 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$4K +$4.41K +200 New
Citigroup
41
Citigroup
New York
$3K +$3.33K +151 New
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$1K +$617 +28 New
Wells Fargo
43
Wells Fargo
California
+$507 +23 New

NEOS Hedge Fund Activity: Q3 2015 in Review

43 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q3 2015, worth a combined $127M.

Buyers outnumbered sellers: 43 funds opened new NEOS positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was DSC Advisors, opening a new position worth an estimated $20M.

  • 43 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q3 2015, up from 0 in Q2 2015.
  • Funds reported $127M of Neos Therapeutics, Inc stock for Q3 2015.
  • 43 funds opened new Neos Therapeutics, Inc positions in Q3 2015 and 0 closed out, a net change of +43 holders.
  • The largest Neos Therapeutics, Inc buyer in Q3 2015 was DSC Advisors, an estimated $20M added.

Based on aggregated 13F filings for Q3 2015.